Zenas BioPharma, Total Revenue from 2010 to 2024
| ZBIO Etf | USD 9.84 0.21 2.09% |
Check Zenas BioPharma, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zenas BioPharma,'s main balance sheet or income statement drivers, such as , as well as many indicators such as . Zenas financial statements analysis is a perfect complement when working with Zenas BioPharma, Valuation or Volatility modules.
Zenas |
About Zenas BioPharma, Financial Statements
Zenas BioPharma, investors utilize fundamental indicators, such as Total Revenue, to predict how Zenas Etf might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
The investment seeks daily investment results, before fees and expenses, that correspond to three times the inverse of the daily performance of the NASDAQ Biotechnology Index. ProShares UltraPro is traded on NGM Exchange in the United States.
Pair Trading with Zenas BioPharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zenas BioPharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will appreciate offsetting losses from the drop in the long position's value.Moving together with Zenas Etf
Moving against Zenas Etf
| 0.83 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.76 | VAXX | Vaxxinity | PairCorr |
| 0.71 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.67 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.6 | FBIOP | Fortress Biotech Pref | PairCorr |
The ability to find closely correlated positions to Zenas BioPharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zenas BioPharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zenas BioPharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zenas BioPharma, Common to buy it.
The correlation of Zenas BioPharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zenas BioPharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zenas BioPharma, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Zenas BioPharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Zenas Etf
Zenas BioPharma, financial ratios help investors to determine whether Zenas Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zenas with respect to the benefits of owning Zenas BioPharma, security.